Summary
- OCID:
- ocds-h6vhtk-05ea44
- Published by:
- Cardiff University
- Authority ID:
- AA0258
- Publication date:
- 16 January 2026
- Deadline date:
- 30 January 2026
- Notice type:
- UK4
- Has documents:
- Yes
- Has SPD:
- No
- Has Carbon Reduction Plan:
- N/A
Abstract
The School of Medicine successfully applied for a UKRI grant to investigate in a randomised controlled trial (RCT), a new IMP (investigational medicinal product) called Triiodothyronine sulphate (T3S) in hypothyroid subjects with a gene difference in a thyroid related enzyme called deiodinase 2 (D2).We are looking for a CDMO to (i) Import and QP sign off T3S and matched placebo tablets obtained from Ardena, Pamplona, Spain who will manufacture these to GMP standards; (ii) over encapsulate commercially secured L-thyroxine (LT4 ) and matched placebo capsules; (iii) store T3S and matched placebo obtained from Ardena, and over encapsulated LT4 and matched placebo; (iv) label T3S, LT4 and respective placebo packs for distribution to trial subjects; (v) distribute T3S and matched placebo and over encapsulated LT4 and matched placebo packs to trial pharmacy (Royal Glamorgan Hospital, Wales).
Full notice text
Scope
Procurement description
The School of Medicine successfully applied for a UKRI grant to investigate in a randomised controlled trial (RCT), a new IMP (investigational medicinal product) called Triiodothyronine sulphate (T3S) in hypothyroid subjects with a gene difference in a thyroid related enzyme called deiodinase 2 (D2).
We are looking for a CDMO to (i) Import and QP sign off T3S and matched placebo tablets obtained from Ardena, Pamplona, Spain who will manufacture these to GMP standards; (ii) over encapsulate commercially secured L-thyroxine (LT4 ) and matched placebo capsules; (iii) store T3S and matched placebo obtained from Ardena, and over encapsulated LT4 and matched placebo; (iv) label T3S, LT4 and respective placebo packs for distribution to trial subjects; (v) distribute T3S and matched placebo and over encapsulated LT4 and matched placebo packs to trial pharmacy (Royal Glamorgan Hospital, Wales).
Delivery regions
- UKL22 - Cardiff and Vale of Glamorgan
Total value (estimated, excluding VAT)
421000 GBP to 421000GBP
Contract dates (estimated)
20 April 2026, 00:00AM to 11 October 2027, 23:59PM
Procedure
Procedure type
Competitive flexible procedure
Reduced Tendering Period
Qualifying planned procurement notice
Is the total value above threshold?
Above threshold
Lots
Divided into 1 lots
Lot number: 1
CPV classifications
- 33600000 - Pharmaceutical products
- 73100000 - Research and experimental development services
Delivery regions
- UKL22 - Cardiff and Vale of Glamorgan
Lot value (estimated)
421000 GBP Excluding VAT
421000 GBP Including VAT
Sustainability
Small and medium-sized enterprises (SME)
Contract start date (estimated)
20 April 2026, 00:00AM
Contract end date (estimated)
11 October 2027, 23:59PM
Participation
Conditions of participation
Relevant professional accreditations - further detail found in Tender Pack
Award criteria
Type: quality
Name
Quality
Weighting: 60.00
Weighting type: percentageExact
Type: quality
Name
Responsible Procurement
Weighting: 10.00
Weighting type: percentageExact
Type: price
Name
Pricing
Weighting: 30.00
Weighting type: percentageExact
Submission
Tender submission deadline
30 January 2026, 23:59PM
Enquiry deadline
28 January 2026, 23:59PM
Date of award of contract
30 March 2026, 23:59PM
Submission address and any special instructions
NDAs are to be returned to the following email addresses - rower4@cardiff.ac.ukprocurement@cardiff.ac.ukRegistration and access to the tender is via our portal - https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
May tenders be submitted electronically?
Yes
Languages that may be used for submission
Documents
Document type
Bidding documents
Description
PLEASE NOTE - Returning of a SIGNED COPY of the attached NDA is required to gain access to the tender on our portal. Please ensure an NDA is sent to the below email addresses without delay to allow us to add your organisation to the tender activity. NDAs returned per the linked PPN UK4 notice will automatically qualify for access to this tender, a second NDA for those who have already returned an NDA is not required.
Once received, you will be added to the portal to review documentation and submit a bid. Please note, we can only add organisations who have an account on our portal, please ensure you have registered, otherwise we will be unable to add you until this is done.
Return of NDA -
rower4@cardiff.ac.uk
procurement@cardiff.ac.uk
Portal -
https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
Document type
Bidding documents
Document type
Upon return of the attached NDA, and registration on or Portal, prospective bidders will have access to all documents on our E-tender portal InTend. Please use the below link to register and access said documents once added to the tender event -
https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
Document type
Conflict of interest
Description
Not published
Coding
Commodity categories
| ID |
Title
|
Parent category
|
|
There are no commodity categories for this notice.
|
Delivery locations
| ID |
Description
|
| 1022 |
Cardiff and Vale of Glamorgan |
Document family
|
Notice details
|
- Publication date:
- 27 November 2025
- Deadline date:
- 13 January 2026 01:00
- Notice type:
- UK3
- Version:
- 1
- Authority name:
- Cardiff University
|
- Publication date:
- 16 January 2026
- Deadline date:
- 30 January 2026 23:59
- Notice type:
- UK4
- Version:
- 1
- Authority name:
- Cardiff University
|
About the buyer
- Main contact:
- n/a
- Admin contact:
- n/a
- Technical contact:
- n/a
- Other contact:
- n/a
Additional documents
The following additional documents have been attached to this notice. To obtain these documents please select the individual file names below.
Current documents
docx29.68 KB
This file may not be accessible.
Replaced documents
There are no previous versions of these documents.